Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.100 | None | 0.980 | 294 | 4 | 1990 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.979 | 283 | 6 | 2002 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
group | 0.100 | None | 0.927 | 260 | 1 | 1991 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.980 | 255 | 8 | 1992 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.945 | 253 | 9 | 1993 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
group | 0.100 | None | 0.987 | 238 | 0 | 2004 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.100 | None | 0.977 | 219 | 0 | 2007 | 2020 | |||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.100 | None | 0.953 | 215 | 13 | 1995 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
group | 0.100 | None | 0.977 | 214 | 0 | 2000 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.100 | None | 0.985 | 201 | 4 | 1995 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.990 | 194 | 5 | 2003 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.984 | 190 | 7 | 1995 | 2020 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
group | 0.100 | None | 0.995 | 186 | 6 | 1998 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.100 | None | 0.967 | 184 | 7 | 1989 | 2020 | ||||||||
|
heat shock protein 90 alpha family class A member 1 | 0.411 | 0.923 | 0.86 |
|
group | 0.100 | None | 0.973 | 183 | 0 | 2004 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.100 | None | 0.945 | 182 | 13 | 1985 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.100 | None | 0.966 | 178 | 10 | 1999 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.100 | None | 0.983 | 176 | 1 | 1994 | 2020 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
group | 0.100 | None | 0.994 | 175 | 2 | 1997 | 2020 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.983 | 173 | 0 | 2004 | 2020 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
group | 0.100 | None | 0.965 | 171 | 6 | 2005 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.100 | None | 1.000 | 171 | 0 | 1986 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.100 | None | 0.965 | 170 | 2 | 1991 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.100 | None | 0.957 | 163 | 3 | 1990 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 0.981 | 160 | 2 | 1989 | 2020 |